Unraveling the germline inheritance of the JAK2 F556V gene mutation in familial thrombocythemia: a comprehensive analysis of 11 family members and potential implications for surveillance
- PMID: 39323414
- PMCID: PMC11788640
- DOI: 10.3324/haematol.2024.285329
Unraveling the germline inheritance of the JAK2 F556V gene mutation in familial thrombocythemia: a comprehensive analysis of 11 family members and potential implications for surveillance
Figures

Similar articles
-
Familial Essential Thrombocythemia With Novel MPL L502G and G208K Mutations.Cureus. 2022 Mar 16;14(3):e23220. doi: 10.7759/cureus.23220. eCollection 2022 Mar. Cureus. 2022. PMID: 35449633 Free PMC article.
-
A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family.Haematologica. 2008 May;93(5):706-14. doi: 10.3324/haematol.11801. Epub 2008 Mar 26. Haematologica. 2008. PMID: 18367486
-
Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance.J Clin Oncol. 2019 May 1;37(13):1070-1080. doi: 10.1200/JCO.18.01512. Epub 2019 Mar 18. J Clin Oncol. 2019. PMID: 30883245 Free PMC article.
-
Overview on population screening for carriers with germline BRCA mutation in China.Front Oncol. 2022 Nov 9;12:1002360. doi: 10.3389/fonc.2022.1002360. eCollection 2022. Front Oncol. 2022. PMID: 36439508 Free PMC article. Review.
-
Familial Colorectal Cancer: Understanding the Alphabet Soup.Clin Colon Rectal Surg. 2016 Sep;29(3):185-95. doi: 10.1055/s-0036-1584290. Clin Colon Rectal Surg. 2016. PMID: 27582643 Free PMC article. Review.
Cited by
-
JAK2 p.R564 germ line variants associated with hereditary thrombocythemia and hematologic neoplasms.Blood Adv. 2025 Apr 8;9(7):1534-1543. doi: 10.1182/bloodadvances.2024013661. Blood Adv. 2025. PMID: 39657124 Free PMC article.
References
-
- Teofili L, Larocca LM. Advances in understanding the pathogenesis of familial thrombocythaemia. Br J Haematol. 2011;152(6): 701-712. - PubMed
-
- Baxter EJ, Scott LM, Campbell PJ, et al. . Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365(9464):1054-1061. - PubMed
-
- Kralovics R, Passamonti F, Buser AS, et al. . A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352(17):1779-1790. - PubMed
-
- Levine RL, Wadleigh M, Cools J, et al. . Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005;7(4):387-397. - PubMed
-
- Han EY, Catherwood M, McMullin MF. Hereditary thrombocytosis: the genetic landscape. Br J Haematol. 2021;194(6):1098-1105. - PubMed
LinkOut - more resources
Full Text Sources